Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-Human Dose-Escalation Study of Vactosertib (TEW-7197) Monotherapy in Subjects With Advanced Stage Solid Tumors

NCT02160106 is registered in ClinicalTrials.gov with MedPacto, Inc. as lead sponsor.

NCT NCT02160106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02160106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-Human Dose-Escalation Study of Vactosertib (TEW-7197) Monotherapy in Subjects With Advanced Stage Solid Tumors
Lead sponsor
MedPacto, Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 29, 2014
Completion date
August 28, 2018
Enrollment
35 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced stage solid tumors